EN
HI

ALIVUS LIFE SCIENCES Share price

ALIVUS

HealthcareLarge

1147

59.00 (-4.89%)
NSE
BSE
Last updated on 16 May, 2025 | 15:29 IST
BUYSELL
Today's High

1200.00

Today's Low

1129.40

52 Week Low

755.95

52 Week High

1335.10

The current prices are delayed, login to your account for live prices

Alivus Life Sciences Chart

ALIVUS LIFE SCIENCES Fundamentals

P/E Ratio

28.89

P/B Ratio

5.24

Div. Yield

1.97

Sector P/E

41.98

Sector P/B

4.77

Sec. Div. Yield

0.33

ALIVUS LIFE SCIENCES Resistance and Support

Pivot 1201.37

Resistance

First Resistance

1229.74

Second Resistance

1253.47

Third Resistance

1281.84

Support

First Support

1177.64

Second Support

1149.27

Third Support

1125.54

ALIVUS LIFE SCIENCES Futures & Options

Data Not Found

ALIVUS LIFE SCIENCES Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    74.99%

    Mutual Fund

    3.59%

    Insurance

    0.22%

    Foreign Institutional Investors

    6.57%

    Domestic Institutional Investors

    1.38%

    Retail

    13.25%

    Others

    0%

    Total Promoters
    MAR '25
    74.99%

    ALIVUS LIFE SCIENCES Corporate Actions

    DateAgenda
    2025-05-15Audited Results & Final Dividend
    2025-01-23Quarterly Results
    DateEvent TypeAgenda
    2025-05-15Board MeetingAudited Results & Final Dividend
    2025-01-23Board MeetingQuarterly Results

    ALIVUS LIFE SCIENCES News

    Under a new owner, Glenmark Life Sciences aims to shed past constraints

    Oct 11 2024 08:26:53
    Read More

    About ALIVUS LIFE SCIENCES AboutThe

    NSE : 5265  
    BSE : 543322  
    ISIN : INE03Q201024  

    The Company was incorporated as ‘Zorg Laboratories Private Limited’ a private limited company under the Companies Act 1956 on June 23 2011 at Pune and was granted the certificate of incorporation by the RoC. the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4 2018. For further details please see – “Details regarding material acquisitions or divestments of business/ undertakings mergers amalgamations or any revaluation of assets in the last 10 years - Acquisition by Glenmark Pharmaceuticals Limited” on page 151. Pursuant to the acquisition the name of the Company was changed to ‘Glenmark Life Sciences Private Limited’ by way of a special resolution passed by the shareholders of the Company on July 25 2018 and a fresh certificate of incorporation dated August 10 2018 was issued by the RoC. A shareholders’ resolution was passed on August 13 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28 2018 was issued by the RoC. Thereafter the business of active pharmaceutical ingredients was acquired by the Company from the Promoter pursuant to the Business Purchase Agreement.Major events and milestones of the Company :2021- Achieved milestone of 403 cumulative drug master files (DMF) registrations across multiple markets globally2019- The API business was spun off into the Company- Ankleshwar plant inspected by US-FDA Health Canada and PMDA Japan2018- Dahej plant inspected by EDQM ANSM and US-FDA- Mohol plant inspected by US-FDA2016- Dahej plant inspected by PMDA Japan2015- Dahej plant inspected by US-FDA2013- Commenced manufacturing at Dahej Gujarat- Ankleshwar plant inspected by COFEPRIS2012- Ankleshwar plant inspected by PMDA and AFSSAPS2008- Ankleshwar plant at Gujarat inspected by US-FDA2004- Commenced manufacturing at Mohol Maharashtra2003- First product registered with US-FDA- Acquired GlaxoSmithKline’s (GSK) API manufacturing plant in Ankleshwar Gujarat2001 - 2002- The Promoter established its API business- Established manufacturing plant at Kurkumbh MaharashtraAwards accreditations and recognitions received by the Company :2021- Ankleshwar plant received ISO 45001:2018 certifying the management system of the manufacturing facility- Ankleshwar plant received ISO 14001:2015 re-certifying the management system of the manufacturing facility2020- Dahej plant received ISO 45001:2018 certifying the management system of the manufacturing facility- Dahej plant was declared the winner of the Greentech Environment Award for the year 2020 for outstanding achievements in environment protection2019- Ankleshwar plant was awarded Greentech Safety Award as the winner in the pharmaceutical sector by the Greentech Foundation for outstanding achievements in safety management- Dahej plant was awarded Greentech Safety Award for the year 2019 as the runner-up in the pharmaceutical sector by the Greentech Foundation for outstanding achievements in safety management- Dahej plant was declared the winner of the Greentech Environment Award for the year 2019 for outstanding achievements in environment management in the pharmaceutical sector2018- Ankleshwar plant received ISO 14001:2015 re-certifying the management system of manufacturing facility- Dahej plant received ISO 14001:2015 re-certifying the management system of manufacturing facility- Ankleshwar plant was awarded Greentech Safety gold award by the Greentech Foundation for outstanding achievements in safety management2017- Ankleshwar plant was awarded Greentech Safety silver award by the Greentech Foundation for outstanding achievements in safety management2016- Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility- Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility2015- Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility

    ALIVUS LIFE SCIENCES Management

    NamePosition
    Mr. Hiren K Patel Chairman & Non-Exe.Director
    Dr. Yasir Rawjee Managing Director & CEO
    Mr. Vinod Naik Executive Director
    Mrs. Manju Agarwal Independent Director
    Mr. Taruvai Laxminarayanan Easwar Independent Director
    Read More

    ALIVUS LIFE SCIENCES FAQs

    ALIVUS LIFE SCIENCES शेयर का खरीद मूल्य 1147 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    ALIVUS LIFE SCIENCES शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    ALIVUS LIFE SCIENCES शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 28.89 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    ALIVUS LIFE SCIENCES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.24 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    ALIVUS LIFE SCIENCES शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.77 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    ALIVUS LIFE SCIENCES का मार्केट कैप 14777.97 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    ALIVUS LIFE SCIENCES शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1335.10 और 755.95 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    ALIVUS LIFE SCIENCES Share Key Metrics

    Volume
    2.18 L
    Market Cap
    14777.97 CR
    LTQ@LTP
    50@1147.00
    ATP
    1153.07
    Var Margin
    20.92 %
    Circuit Range
    964.8-1447.2
    Delivery %
    36.83 %
    Value
    25.13 CR
    ASM/GSM
    No
    Market Lot
    1